IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,595 | +96.5% | 9,419 | -2.9% | 0.00% | +100.0% |
| Q2 2023 | $184,009 | +100.4% | 9,700 | +63.9% | 0.00% | – |
| Q1 2023 | $91,819 | -29.1% | 5,920 | -18.8% | 0.00% | -100.0% |
| Q4 2022 | $129,433 | +187.6% | 7,292 | -9.7% | 0.00% | – |
| Q3 2022 | $45,000 | +45.2% | 8,076 | 0.0% | 0.00% | – |
| Q2 2022 | $31,000 | -29.5% | 8,076 | 0.0% | 0.00% | – |
| Q1 2022 | $44,000 | -8.3% | 8,076 | +43.4% | 0.00% | – |
| Q4 2021 | $48,000 | -4.0% | 5,631 | -2.1% | 0.00% | – |
| Q3 2021 | $50,000 | -18.0% | 5,751 | -0.1% | 0.00% | – |
| Q2 2021 | $61,000 | -33.7% | 5,757 | +0.9% | 0.00% | -100.0% |
| Q1 2021 | $92,000 | -55.6% | 5,705 | +27.2% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | +65.6% | 4,484 | +26.1% | 0.00% | 0.0% |
| Q3 2020 | $125,000 | – | 3,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |